1.5020
+0.0320
+(2.18%)
At close: January 10 at 8:07:38 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-574.9610
-1,847.5790
-3,626.4200
-4,817.2760
Investing Cash Flow
--
-14,503.5530
-14,271.3280
-11,724.1790
-9,081.5360
Financing Cash Flow
--
6,021.1670
8,709.9670
4,122.7990
18,381.5020
End Cash Position
--
12,256.9120
21,316.8840
28,724.7380
39,604.8880
Capital Expenditure
--
-14,502.6000
-14,270.6760
-11,761.1960
-9,223.0920
Issuance of Capital Stock
--
--
--
--
22,084.3673
Issuance of Debt
--
15,514.5400
14,068.4890
7,960.1510
7,066.6730
Repayment of Debt
--
-7,613.8170
-4,426.2550
-3,837.3520
-6,866.1780
Free Cash Flow
--
-15,077.5610
-16,118.2550
-15,387.6160
-14,040.3680
12/31/2020 - 4/6/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
7IZ.MU Ziccum AB
0.0298
-29.72%
5KW.F SkinBioTherapeutics plc
0.1720
+1.18%
HQ1.MU Oruka Therapeutics Inc. R
18.60
0.00%
4AJ0.SG Alk-Abello A/S
19.46
+0.46%
41X.F Ardelyx, Inc.
5.12
+0.16%
PH4.F CStone Pharmaceuticals
0.2640
-1.49%
BLE.BE bluebird bio Inc
0.3708
-3.01%
XRP2.F Silence Therapeutics plc
5.95
+0.85%
GBY.SG Sangamo Therapeutics Inc
1.1002
-8.41%
RGO.HA Regeneron Pharmaceuticals Inc
683.60
-2.73%